有偏向的多巴胺 D2 受体在不同的亚细胞区表现出不同的胞内贩运特性和 ERK 激活。

IF 3 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Biomolecules & Therapeutics Pub Date : 2024-01-01 Epub Date: 2023-07-19 DOI:10.4062/biomolther.2023.033
Shujie Wang, Lulu Peng, Kyeong-Man Kim
{"title":"有偏向的多巴胺 D2 受体在不同的亚细胞区表现出不同的胞内贩运特性和 ERK 激活。","authors":"Shujie Wang, Lulu Peng, Kyeong-Man Kim","doi":"10.4062/biomolther.2023.033","DOIUrl":null,"url":null,"abstract":"<p><p>Biased signaling or functional selectivity refers to the ability of an agonist or receptor to selectively activate a subset of transducers such as G protein and arrestin in the case of G protein-coupled receptors (GPCRs). Although signaling through arrestin has been reported from various GPCRs, only a few studies have examined side-by-side how it differs from signaling via G protein. In this study, two signaling pathways were compared using dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) mutants engineered via the evolutionary tracer method to selectively transduce signals through G protein or arrestin (D<sub>2</sub>G and D<sub>2</sub>Arr, respectively). D<sub>2</sub>G mediated the inhibition of cAMP production and ERK activation in the cytoplasm. D<sub>2</sub>Arr, in contrast, mediated receptor endocytosis accompanied by arrestin ubiquitination and ERK activation in the nucleus as well as in the cytoplasm. D<sub>2</sub>Arr-mediated ERK activation occurred in a manner dependent on arrestin3 but not arrestin2, accompanied by the nuclear translocation of arrestin3 via importin1. D<sub>2</sub>R-mediated ERK activation, which occurred in both the cytosol and nucleus, was limited to the cytosol when cellular arrestin3 was depleted. This finding supports the results obtained with D<sub>2</sub>Arr and D<sub>2</sub>G. Taken together, these observations indicate that biased signal transduction pathways activate distinct downstream mechanisms and that the subcellular regions in which they occur could be different when the same effectors are involved. These findings broaden our understanding on the relation between biased receptors and the corresponding downstream signaling, which is critical for elucidating the functional roles of biased pathways.</p>","PeriodicalId":8949,"journal":{"name":"Biomolecules & Therapeutics","volume":" ","pages":"56-64"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762269/pdf/","citationCount":"0","resultStr":"{\"title\":\"Biased Dopamine D<sub>2</sub> Receptors Exhibit Distinct Intracellular Trafficking Properties and ERK Activation in Different Subcellular Domains.\",\"authors\":\"Shujie Wang, Lulu Peng, Kyeong-Man Kim\",\"doi\":\"10.4062/biomolther.2023.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Biased signaling or functional selectivity refers to the ability of an agonist or receptor to selectively activate a subset of transducers such as G protein and arrestin in the case of G protein-coupled receptors (GPCRs). Although signaling through arrestin has been reported from various GPCRs, only a few studies have examined side-by-side how it differs from signaling via G protein. In this study, two signaling pathways were compared using dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) mutants engineered via the evolutionary tracer method to selectively transduce signals through G protein or arrestin (D<sub>2</sub>G and D<sub>2</sub>Arr, respectively). D<sub>2</sub>G mediated the inhibition of cAMP production and ERK activation in the cytoplasm. D<sub>2</sub>Arr, in contrast, mediated receptor endocytosis accompanied by arrestin ubiquitination and ERK activation in the nucleus as well as in the cytoplasm. D<sub>2</sub>Arr-mediated ERK activation occurred in a manner dependent on arrestin3 but not arrestin2, accompanied by the nuclear translocation of arrestin3 via importin1. D<sub>2</sub>R-mediated ERK activation, which occurred in both the cytosol and nucleus, was limited to the cytosol when cellular arrestin3 was depleted. This finding supports the results obtained with D<sub>2</sub>Arr and D<sub>2</sub>G. Taken together, these observations indicate that biased signal transduction pathways activate distinct downstream mechanisms and that the subcellular regions in which they occur could be different when the same effectors are involved. These findings broaden our understanding on the relation between biased receptors and the corresponding downstream signaling, which is critical for elucidating the functional roles of biased pathways.</p>\",\"PeriodicalId\":8949,\"journal\":{\"name\":\"Biomolecules & Therapeutics\",\"volume\":\" \",\"pages\":\"56-64\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762269/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomolecules & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4062/biomolther.2023.033\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/7/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomolecules & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4062/biomolther.2023.033","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

偏向信号传导或功能选择性是指激动剂或受体选择性激活子集传导因子的能力,如 G 蛋白和 G 蛋白偶联受体(GPCR)中的捕获素。尽管各种 GPCR 都报道了通过 arrestin 发出信号的情况,但只有少数研究并列研究了它与通过 G 蛋白发出信号的不同之处。在本研究中,通过进化示踪法设计的多巴胺 D2 受体(D2R)突变体选择性地通过 G 蛋白或 arrestin(分别为 D2G 和 D2Arr)传递信号,比较了两种信号传递途径。D2G 可抑制细胞质中 cAMP 的产生和 ERK 的激活。与此相反,D2Arr 介导的受体内吞伴随着 arrestin 泛素化以及细胞核和细胞质中的 ERK 激活。D2Arr 介导的 ERK 激活是以依赖于 arrestin3 而非 arrestin2 的方式发生的,同时伴随着 arrestin3 通过导入素 1 的核转位。D2R介导的ERK活化同时发生在细胞质和细胞核中,但当细胞抑制素3被耗尽时,ERK活化仅限于细胞质。这一发现支持了 D2Arr 和 D2G 的研究结果。综上所述,这些观察结果表明,有偏向的信号转导途径会激活不同的下游机制,而且当涉及相同的效应因子时,它们发生作用的亚细胞区域也可能不同。这些发现拓宽了我们对偏倚受体与相应下游信号转导之间关系的理解,这对阐明偏倚途径的功能作用至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Biased Dopamine D2 Receptors Exhibit Distinct Intracellular Trafficking Properties and ERK Activation in Different Subcellular Domains.

Biased signaling or functional selectivity refers to the ability of an agonist or receptor to selectively activate a subset of transducers such as G protein and arrestin in the case of G protein-coupled receptors (GPCRs). Although signaling through arrestin has been reported from various GPCRs, only a few studies have examined side-by-side how it differs from signaling via G protein. In this study, two signaling pathways were compared using dopamine D2 receptor (D2R) mutants engineered via the evolutionary tracer method to selectively transduce signals through G protein or arrestin (D2G and D2Arr, respectively). D2G mediated the inhibition of cAMP production and ERK activation in the cytoplasm. D2Arr, in contrast, mediated receptor endocytosis accompanied by arrestin ubiquitination and ERK activation in the nucleus as well as in the cytoplasm. D2Arr-mediated ERK activation occurred in a manner dependent on arrestin3 but not arrestin2, accompanied by the nuclear translocation of arrestin3 via importin1. D2R-mediated ERK activation, which occurred in both the cytosol and nucleus, was limited to the cytosol when cellular arrestin3 was depleted. This finding supports the results obtained with D2Arr and D2G. Taken together, these observations indicate that biased signal transduction pathways activate distinct downstream mechanisms and that the subcellular regions in which they occur could be different when the same effectors are involved. These findings broaden our understanding on the relation between biased receptors and the corresponding downstream signaling, which is critical for elucidating the functional roles of biased pathways.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.60
自引率
8.10%
发文量
72
审稿时长
6-12 weeks
期刊介绍: Biomolecules & Therapeutics (Biomolecules & Therapeutics) (Print ISSN 1976-9148, Online ISSN 2005-4483) is an international, peer-reviewed, open access journal that covers pharmacological and toxicological fields related to bioactive molecules and therapeutics. It was launched in 1993 as "The Journal of Applied Pharmacology (ISSN 1225-6110)", and renamed "Biomolecules & Therapeutics" (Biomol Ther: abbreviated form) in 2008 (Volume 16, No. 1). It is published bimonthly in January, March, May, July, September and November. All manuscripts should be creative, informative, and contribute to the development of new drugs. Articles in the following categories are published: review articles and research articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信